Fleury Group to License IDbyDNA NGS Platform

Sep 19, 2018

|

The story has been amended to update the number of bacterial, fungal, and viral respiratory pathogens detected by IDbyDNA's technology.

NEW YORK (GenomeWeb) – IDbyDNA announced today that it has signed a licensing agreement with Brazil-based Fleury Group to offer IDbyDNA's Explify platform for clinical metagenomic testing in South America.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Fleury Group to License IDbyDNA NGS Platform

To read the full story....

Breaking News

Quest Acquires Mercy's Outreach Lab Business

Bio-Rad Laboratories, Roche Enter Quality Control Partnership

Ortho Clinical Diagnostics Nabs CE Mark for Semi-Quantitative SARS-CoV-2 Antibody Tests

UK Government Introduces Free COVID-19 Workplace Testing Program

FDA Issues EUA for Adaptive Biotechnologies COVID-19 T-Cell Response Test

Cue Health Over-the-Counter COVID-19 Test Gets FDA Emergency Use Authorization

What's Popular?

Quest Acquires Mercy's Outreach Lab Business

Abbott Gets FDA EUA for Test That Detects Coronavirus, Three Other Respiratory Infections

OraSure Technologies Updates Plan for SARS-CoV-2 Antigen Self-Test

Fulgent Genetics Aims to Use COVID-19 Testing Gains to Grow Clinical Sequencing Business

Norwegian Startup Pre Diagnostics Developing Monocyte Test for Presymptomatic Alzheimer's Disease

Sponsorships